Ancora Advisors, LLC Emergent Bio Solutions Inc. Transaction History

Ancora Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $25,900 - $37,076	710 New	710 $66,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $2,648 - $4,400	-80 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $4,506 - $5,944	-90 Reduced 52.94%	80 $4,000
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $30,569 - $43,448	-540 Reduced 76.06%	170 $11,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $2.35 Million - $3.42 Million	-27,309 Reduced 97.47%	710 $66,000
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $808,325 - $1.14 Million	10,210 Added 57.33%	28,019 $2.51 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $1.16 Million - $1.92 Million	-14,199 Reduced 44.36%	17,809 $1.84 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $629,684 - $1.04 Million	11,590 Added 56.76%	32,008 $2.53 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $334,919 - $466,742	6,788 Added 49.8%	20,418 $1.18 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $16,899 - $19,489	330 Added 2.48%	13,630 $735,000
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $539,980 - $760,760	13,300 New	13,300 $695,000

158

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $493M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.